Am J Epidemiol 2003; 158:486-494.
Copyright © 2003 by Johns
Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Determinants of Clearance of Human Papillomavirus Infections in Colombian Women with Normal Cytology: A Population-based, 5-Year Follow-up Study
1 Department of Pathology, Vrije Universiteit Medical Centre, Amsterdam, the Netherlands.
2 Division de Investigacion, Instituto Nacional de Cancerologia, Bogota, Colombia.
3 International Agency for Research on Cancer, Lyon, France.
Little is known about the factors that influence clearance of human papillomavirus (HPV), the primary cause of cervical carcinoma. A total of 227 women cytologically normal and HPV positive at baseline were identified from a population-based cohort of 1,995 Bogota, Colombia, women aged 13–85 years followed between 1993 and 2000 (mean follow-up, 5.3 years). HPV DNA detection and viral load determination were based on a GP5+/GP6+ polymerase chain reaction enzyme immunoassay. Rate ratio estimates for HPV clearance were calculated by using methods for interval-censored survival time data. Analyses were based on 316 type-specific HPV infections. HPV 16 had a significantly lower clearance rate than infections with low-risk types (rate ratio (RR) = 0.47, 95% confidence interval (CI): 0.32, 0.72), HPV types related to HPV 16 (types 31, 33, 35, 52, 58) had intermediate clearance rates (RR = 0.62, 95% CI: 0.47, 0.94), and other high-risk types did not show evidence of slower clearance compared with low-risk types. Infections with single and multiple HPV types had similar clearance rates. There was no evidence of a dose-response relation between clearance and viral load. Observed was slower clearance in parous women (RR = 0.64, 95% CI: 0.47, 0.89) and faster clearance in ever users of oral contraceptives (RR = 1.38, 95% CI: 1.07, 1.77).
cervix neoplasms; cohort studies; cytology; oral contraceptives; papillomavirus
Abbreviations: Abbreviations: CIN III, cervical intraepithelial neoplasia, grade III; EIA, enzyme immunoassay; HPV, human papillomavirus; PCR, polymerase chain reaction.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Lazarczyk, P. Cassonnet, C. Pons, Y. Jacob, and M. Favre The EVER Proteins as a Natural Barrier against Papillomaviruses: a New Insight into the Pathogenesis of Human Papillomavirus Infections Microbiol. Mol. Biol. Rev., June 1, 2009; 73(2): 348 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Syrjanen, T. Waterboer, M. Sarkola, K. Michael, M. Rintala, K. Syrjanen, S. Grenman, and M. Pawlita Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy J. Gen. Virol., June 1, 2009; 90(6): 1515 - 1526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Goodman, Y. B. Shvetsov, K. McDuffie, L. R. Wilkens, X. Zhu, P. J. Thompson, L. Ning, J. Killeen, L. Kamemoto, and B. Y. Hernandez Prevalence, Acquisition, and Clearance of Cervical Human Papillomavirus Infection among Women with Normal Cytology: Hawaii Human Papillomavirus Cohort Study Cancer Res., November 1, 2008; 68(21): 8813 - 8824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Koshiol, L. Lindsay, J. M. Pimenta, C. Poole, D. Jenkins, and J. S. Smith Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis Am. J. Epidemiol., July 15, 2008; 168(2): 123 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Safaeian, M. Kiddugavu, P. E. Gravitt, S. J. Gange, J. Ssekasanvu, D. Murokora, M. Sklar, D. Serwadda, M. J. Wawer, K. V. Shah, et al. Determinants of Incidence and Clearance of High-Risk Human Papillomavirus Infections in Rural Rakai, Uganda Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1300 - 1307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Vaccarella, R. Herrero, P. J F Snijders, M. Dai, J. O Thomas, N. T. Hieu, C. Ferreccio, E. Matos, H. Posso, S. de Sanjose, et al. Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys Int. J. Epidemiol., June 1, 2008; 37(3): 536 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Tabora, A. Ferrera, J. M. J. E. Bakkers, L. F. A. G. Massuger, and W. J. G. Melchers High HPV 16 Viral Load is Associated with Increased Cervical Dysplasia in Honduran Women Am J Trop Med Hyg, May 1, 2008; 78(5): 843 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Goodman, Y. B. Shvetsov, K. McDuffie, L. R. Wilkens, X. Zhu, A. A. Franke, C. C. Bertram, B. Kessel, M. Bernice, C. Sunoo, et al. Hawaii Cohort Study of Serum Micronutrient Concentrations and Clearance of Incident Oncogenic Human Papillomavirus Infection of the Cervix Cancer Res., June 15, 2007; 67(12): 5987 - 5996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Insinga, E. J. Dasbach, E. H. Elbasha, K.-L. Liaw, and E. Barr Incidence and Duration of Cervical Human Papillomavirus 6, 11, 16, and 18 Infections in Young Women: An Evaluation from Multiple Analytic Perspectives Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 709 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Gunnell, T. N. Tran, A. Torrang, P. W. Dickman, P. Sparen, J. Palmgren, and N. Ylitalo Synergy between Cigarette Smoking and Human Papillomavirus Type 16 in Cervical Cancer In situ Development Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2141 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Koshiol, J. Schroeder, D. J. Jamieson, S. W. Marshall, A. Duerr, C. M. Heilig, K. V. Shah, R. S. Klein, S. Cu-Uvin, P. Schuman, et al. Smoking and Time to Clearance of Human Papillomavirus Infection in HIV-Seropositive and HIV-Seronegative Women Am. J. Epidemiol., July 15, 2006; 164(2): 176 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Vaccarella, S. Franceschi, R. Herrero, N. Munoz, P. J.F. Snijders, G. M. Clifford, J. S. Smith, E. Lazcano-Ponce, S. Sukvirach, H.-R. Shin, et al. Sexual Behavior, Condom Use, and Human Papillomavirus: Pooled Analysis of the IARC Human Papillomavirus Prevalence Surveys. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 326 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Samoff, E. H. Koumans, L. E. Markowitz, M. Sternberg, M. K. Sawyer, D. Swan, J. R. Papp, C. M. Black, and E. R. Unger Association of Chlamydia trachomatis with Persistence of High-Risk Types of Human Papillomavirus in a Cohort of Female Adolescents Am. J. Epidemiol., October 1, 2005; 162(7): 668 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Sasagawa, M Tani, H Yasuda, K A Khadijeh, A Sakai, T Fukae, T Ukita, H Yamazaki, S Satake, T Nakano, et al. Sexual behaviour and high risk human papillomavirus infections in Japanese women Sex Transm Inf, June 1, 2005; 81(3): 280 - 282. [Full Text] [PDF]
|
|
|
|
|
|
H. Richardson, M. Abrahamowicz, P.-P. Tellier, G. Kelsall, R. du Berger, A. Ferenczy, F. Coutlee, and E. L. Franco Modifiable Risk Factors Associated with Clearance of Type-Specific Cervical Human Papillomavirus Infections in a Cohort of University Students Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1149 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Clifford, R. K. Rana, S. Franceschi, J. S. Smith, G. Gough, and J. M. Pimenta Human Papillomavirus Genotype Distribution in Low-Grade Cervical Lesions: Comparison by Geographic Region and with Cervical Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1157 - 1164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Kreimer, G. M. Clifford, P. Boyle, and S. Franceschi Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 467 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J del Amo, C Gonzalez, J Losana, P Clavo, L Munoz, J Ballesteros, A Garcia-Saiz, M J Belza, M Ortiz, B Menendez, et al. Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain Sex Transm Inf, February 1, 2005; 81(1): 79 - 84. [Abstract] [Full Text] [PDF]
|
|